Biochip and methods of use and preparation thereof

CN118974236APending Publication Date: 2024-11-15SHENZHEN HUADA SANJIAN QIFA TECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202280094382.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2022-09-30
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

When performing spatial omics or spatiotemporal omics processing, it is difficult to distinguish and identify different biochips, leading to problems such as matching errors.

Method used

Design a biochip that has a plurality of characteristic sites arranged in an array on the front side, and is attached with biomolecule sequences, including positioning sequences and capture sequences, and is provided with a first mark identifiable by the human eye and identifiable by an instrument on the back side A second marker to distinguish and identify the chip.

Benefits of technology

Through the unique labeling of biochips, the accuracy and throughput of biological detection are improved, ensuring the correct differentiation and identification of chips, reducing matching errors, and improving the efficiency of spatial omics analysis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118974236A_ABST
    Figure CN118974236A_ABST
Patent Text Reader

Abstract

A biochip (100) and methods of use and preparation thereof. The biochip (100) comprises: a solid support having a front side (101) and a back side (102); a plurality of feature sites (110) arranged in an array and a plurality of biomolecule sequences attached to the plurality of feature sites (110) are formed on the front surface (101), each biomolecule sequence at least comprises a positioning sequence, and the positioning sequence comprises information indicating the spatial position of the biomolecule sequence on the biochip (100). And the back surface (102) is provided with at least one of a first mark (120) which can be recognized by human eyes and a second mark (130) which can be recognized by an instrument.
Need to check novelty before this filing date? Find Prior Art

Description

Biochip and its use and preparation method Technical Field

[0001] Embodiments of the present disclosure generally relate to the field of biotechnology, and more specifically, to a biochip with an identifiable marker and a method for using and preparing the same. The biochip can be used, for example, in a spatial omics or spatiotemporal omics analysis instrument to perform spatial omics in situ information labeling, capture, etc. Background Art

[0002] Spatial heterogeneity is a key characteristic of biological organ function, and the positional information of biological cells is crucial for studying the mechanisms regulating cell fate and the development of cell lineages. Therefore, to better understand biological cells, it is necessary to simultaneously record their transcriptional heterogeneity and spatial coordinates. Generally, this technology, which quantifies transcriptional expression while simultaneously recording spatial coordinates, is referred to as "spatial transcriptomics sequencing technology." By superimposing information from samples at different time stages, this technology can provide researchers with information in both time and space, and is therefore also referred to as "spatiotemporal omics" technology.

[0003] Nucleic acid or gene sequencing (e.g., DNA sequencing and RNA sequencing) is one of the important methods for studying biological nucleic acids or genes. As part of gene sequencing, spatial omics technologies involving spatial dimensions or spatiotemporal omics technologies involving both temporal and spatial dimensions use biochip technology to load probes with spatial location information onto chips. These chips capture target nucleic acids or proteins in biological tissues, then convert the captured information or products into corresponding nucleotide sequences through biochemical reactions and recover them. Finally, the cDNA or RNA in the recovered samples is sequenced through second-generation sequencing, and the captured information and spatial coordinates are matched one-to-one. The read content is superimposed on the tissue image, thereby generating a complete gene expression image of the tissue section, providing a new research direction for understanding organ structure, life development, human diseases, and species evolution. This technology is extremely valuable in clinical research and cancer diagnosis.

[0004] When performing spatial or spatiotemporal omics processing or sequencing operations, it is often necessary to automatically or manually distinguish or identify different biochips. For example, this is used to understand the biochemical reaction processes on each chip and establish a correspondence or matching relationship between the captured products and sequencing data obtained and the biological tissue being examined. In practice, these operations often involve multiple chips with similar appearances. During manual or automated operations, problems such as difficulty distinguishing between different chips and matching errors may occur.

[0005] Summary of the Invention

[0006] The present disclosure is proposed to overcome at least one of the above and other problems and drawbacks of the prior art.

[0007] According to one aspect of the present disclosure, an embodiment provides a biochip comprising: a solid support having a front side and a back side; a plurality of characteristic sites arranged in an array and a plurality of biomolecule sequences attached to the plurality of characteristic sites formed on the front side, each biomolecule sequence comprising at least a positioning sequence, the positioning sequence containing information indicating the spatial position of the biomolecule sequence on the biochip; and at least one of a first mark recognizable by the human eye and a second mark recognizable by an instrument is provided on the back side.

[0008] In some embodiments, each biomolecule sequence further includes a probe for capturing the biological species.

[0009] In some embodiments, the probe comprises at least a capture sequence, which is connected to a positioning sequence and is capable of biochemically reacting with the biological substance to be captured.

[0010] In some embodiments, each characteristic site is attached to one or more copies of a biomolecule sequence, and the positioning sequences of the multiple copies of the biomolecule sequence attached to the same characteristic site are the same.

[0011] In some embodiments, the biomolecule sequence comprises a nucleic acid molecule, such as a DNA nanosphere.

[0012] In some embodiments, each biomolecule sequence further comprises an anchor sequence that allows a complementary nucleotide sequence to anneal and initiate an extension reaction.

[0013] In some embodiments, the nucleic acid molecule comprises a unique molecular identifier (UMI) sequence, and the positioning sequence comprises a coordinate identification (CID) sequence.

[0014] In some embodiments, at least the positioning sequences of the biomolecule sequences attached to different feature sites are different.

[0015] In some embodiments, the position of each characteristic site on the front side is mapped one-to-one to the spatial position indicated by the positioning sequence of the biomolecule sequence attached to the characteristic site.

[0016] In some embodiments, the feature sites are defined by grooves, micropores, protrusions, or modified planar areas formed on the front surface.

[0017] In some embodiments, the center-to-center spacing between adjacent feature sites is in the range of 100 nm to 800 nm.

[0018] In some embodiments, the first label and / or the second label contain unique identification information for determining the identity of the biochip.

[0019] In some embodiments, the first mark includes a character number, and the second mark includes a QR code, a barcode, or an electronic tag.

[0020] In some embodiments, both the first marking and the second marking are arranged side by side on the back surface.

[0021] In some embodiments, the biochip has a rectangular shape with dimensions ranging from 0.5 cm x 0.5 cm to 10 cm x 10 cm, for example, a rectangular shape with dimensions ranging from 1 cm x 1 cm to 6 cm x 6 cm.

[0022] In some embodiments, the biochip is made of silicon, glass or polymer material.

[0023] According to another aspect of the present disclosure, an embodiment proposes a method for analyzing spatial omics information of a biological tissue sample, comprising: placing the biological tissue sample on the front side of the biochip described in any embodiment of the present disclosure, and loading the biochip into an analytical instrument; causing the biological tissue sample to undergo a biochemical reaction with the multiple biomolecule sequences of the biochip to produce a reaction product containing the positioning sequence; and analyzing the reaction product to restore the spatial position information of the cells in the biological tissue sample based on the spatial position indicated by the positioning sequence.

[0024] In some embodiments, the method further comprises: before loading the biochip into an analytical instrument, entering the unique identification information of the biochip into the analytical instrument based on the first mark and / or the second mark.

[0025] According to another aspect of the present disclosure, an embodiment provides a method for preparing a biochip described in any embodiment of the present disclosure, comprising: providing a substrate having a front side and a back side; forming at least one of the first mark and the second mark on the back side of the substrate; forming a plurality of characteristic sites arranged in an array on the front side of the substrate; and attaching a plurality of biomolecule sequences to the plurality of characteristic sites by physical or chemical methods, each biomolecule sequence including at least a positioning sequence, and the positioning sequence containing information indicating the spatial position of the biomolecule sequence on the biochip.

[0026] In some embodiments, the first mark or the second mark is formed on the back surface by at least one of etching, coating, pasting, and printing.

[0027] In some embodiments, the substrate comprises a silicon wafer, a glass plate, or a polymer film, and the method further comprises: after a plurality of biological molecule sequences are attached to the front side, cutting the substrate into a plurality of chip units, each of the cut chip units having at least one of a first mark and a second mark that is uniquely corresponding to the chip unit and having a predetermined size to be used as a single biochip.

[0028] Other objects and advantages of the present disclosure will become apparent from the following detailed description of the present disclosure with reference to the accompanying drawings, which will help to provide a comprehensive understanding of the present disclosure. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] The features and advantages of the present disclosure can be more clearly understood by referring to the accompanying drawings, which are schematic and should not be construed as limiting the present disclosure in any way. In the accompanying drawings:

[0030] FIG1 is a rear view schematically showing a substrate including a plurality of undivided chip units according to an exemplary embodiment of the present disclosure;

[0031] FIG2 is a front view schematically showing a biochip according to an exemplary embodiment of the present disclosure;

[0032] FIG3 is a back view schematically showing a biochip according to an exemplary embodiment of the present disclosure;

[0033] FIG4 is a partially enlarged perspective view schematically showing the structure of a portion of a biochip according to an exemplary embodiment of the present disclosure;

[0034] FIG5 is a cross-sectional view schematically illustrating the structure of a biochip according to an exemplary embodiment of the present disclosure;

[0035] FIG6 is a block diagram schematically illustrating a method for analyzing spatial omics information of a biological tissue sample using a biochip according to an exemplary embodiment of the present disclosure; and

[0036] FIG. 7 is a block diagram schematically illustrating a method of preparing a biochip according to an exemplary embodiment of the present disclosure. DETAILED DESCRIPTION

[0037] The following will be combined with the accompanying drawings in the embodiments of the present disclosure to clearly and completely describe the technical solutions in the embodiments of the present disclosure. Obviously, the embodiments described are only part of the embodiments of the present disclosure, not all of the embodiments. Based on the embodiments of the present disclosure, all other embodiments obtained by ordinary technicians in this field without making any creative efforts are within the scope of protection of the present disclosure.

[0038] In addition, in the detailed description below, for ease of explanation, many specific details are set forth to provide a comprehensive understanding of the embodiments of the present disclosure. However, it is apparent that one or more embodiments can be implemented without these specific details. In other cases, well-known structures and devices are embodied in a schematic manner to simplify the drawings.

[0039] Spatial omics technologies (such as spatial genomics, spatial transcriptomics, spatial proteomics, and spatial immunogenomics) use biochips as carriers to convert information within biological tissues into a detectable form through biochemical reactions. This involves repeated rounds of manual or automated operations, as well as multiple steps of biochemical reactions based on different principles. During these operations or in different biochemical reactions, it is usually necessary to distinguish or identify different biochips, such as for entering chip information, associating each chip with the spatial omics processing flow, determining the biochemical reaction progress on each chip, and establishing a correspondence or matching relationship between the obtained capture products, sequencing data, and the detected biological tissues.

[0040] According to exemplary embodiments of the present disclosure, a biochip is provided that can be used, for example, in a spatial omics or spatiotemporal omics processing instrument to perform spatial omics in situ information labeling, capture, etc. As described below, the biochip provided according to exemplary embodiments of the present disclosure has at least one label that facilitates on-chip differentiation or identification, thereby more effectively improving the accuracy and throughput of biological detection.

[0041] FIG1 schematically illustrates the back side 11 of a substrate 1. The substrate 1 may be in the form of a wafer and may include a plurality of chip units arranged in an array according to exemplary embodiments of the present disclosure. A single chip unit is referred to herein as a biochip 100. The substrate 1 may be made of a silicon wafer, a glass plate, a polymer film, or the like. Individual chip units may be cut from the substrate 1 in a cutting manner, such as by manual tools, automated cutting equipment such as a laser cutter, or the like, to serve as the biochip 100. It will be understood that in some applications, the uncut substrate itself having the plurality of chip units arranged in an array may also be referred to as or used as a biochip.

[0042] The shape of the cut biochip is not limited and can be rectangular, such as a rectangle or a square, or can be a non-standard size chip, for example, having any size within the range of 0.5 cm × 0.5 cm to 10 cm × 10 cm, such as 0.5 cm × 0.5 cm, 1 cm × 1 cm, 1 cm × 2 cm, 2 cm × 3 cm, 3 cm × 4 cm, 3 cm × 5 cm, 4 cm × 6 cm, 5 cm × 6 cm, 6 cm × 6 cm, 6 cm × 7 cm, 7 cm × 7 cm, 7 cm × 8 cm, 8 cm × 8 cm, 8 cm × 9 cm, 9 cm × 9 cm, 9 cm × 10 cm, 10 cm × 10 cm, etc. As an example, the thickness T of the provided biochip can be 400 to 1000 μm, preferably 725 μm.

[0043] The biochip described herein includes a solid support or carrier, which can be the uncut substrate itself or a portion cut from the substrate 1. The biochip has a front side and an opposite back side. For example, the biochip 100 shown in Figures 2 and 3 has a front side 101 and a back side 102. It will be understood that the terms "front side" and "back side" described herein simply refer to the two opposite surfaces of the chip and are not intended to limit these surfaces to a specific orientation or direction. As shown in Figure 2, a plurality of characteristic sites 110 arranged in an array are formed on the front side 101 of the biochip 100, and a plurality of biomolecule sequences (not shown) attached (e.g., connected or fixed) to the plurality of characteristic sites 110. Each biomolecule sequence includes at least a positioning sequence, such as a barcode sequence, which contains information indicating the spatial location of the biomolecule sequence on the biochip. As an example, the positioning sequence can include a coordinate identifier (CID) sequence, such as determined by sequencing. The CID corresponds one-to-one with the coordinate position of each biomolecule sequence. By establishing a mapping relationship between the CID and the coordinate position, subsequently captured biological substances can be restored to their spatial location.

[0044] As an example, the biomolecule sequences carried on the biochip may include genes or nucleic acid molecules (such as DNA or RNA fragments), proteins, polypeptides, polysaccharide molecules, etc. Specifically, the biomolecule sequence may include a vector sequence attached to a characteristic site, and the positioning sequence may be a part of the vector sequence. In some examples, the vector sequence or the positioning sequence may include a nucleic acid sequence, such as a nucleotide sequence or a single-stranded DNA sequence. For example, a vector sequence containing multiple copies may be obtained by subjecting the complementary sequence of the vector sequence to an amplification reaction, such as rolling circle replication (RCA) or PCR amplification.

[0045] Exemplarily, for example, in spatial omics analysis, the biomolecule sequence attached to the characteristic site 110 can be used to capture (such as identifying, binding or hybridizing) target cellular substances in biological tissues, and can also be used to connect probes or capture sequences for such capture on a carrier sequence in a subsequent reaction, so that the captured object or reaction product carries the positioning sequence or corresponding spatial position information. In an exemplary embodiment, each biomolecule sequence can also include a probe for capturing target biological substances, such as a probe cluster having one or more probes. The probe includes at least a capture sequence, which is connected to a carrier sequence, such as a positioning sequence, and the capture sequence is capable of biochemically reacting with the biological substance to be captured to capture cellular substances in biological tissues, such as capturing target nucleic acids or proteins, such as mRNA, in a biological tissue slice placed on the front of the chip. The capture sequence can hybridize with all or part of the nucleic acid to be captured, for example, it can include an oligonucleotide sequence capable of capturing mRNA, or a random or degenerate oligonucleotide sequence, or a specific sequence for a specific target nucleic acid.

[0046] In some embodiments, the carrier sequence on the cut biochip may further include a fixed sequence (also referred to as a "linker sequence") that allows annealing to a complementary nucleotide sequence and initiates an extension reaction; each biomolecule sequence may further include a first nucleic acid molecule and a second nucleic acid molecule, the first nucleic acid molecule having a complementary sequence to hybridize with the fixed sequence and positioning sequence of the carrier sequence to form a double strand, and the second nucleic acid molecule being linked to the first nucleic acid molecule (via a ligase) and may include a capture sequence used as part of a probe. In other embodiments, a fixed sequence may be pre-attached to the chip, and during subsequent use, the nucleic acid molecule with the capture sequence may be linked to the fixed sequence through a suitable biochemical reaction, and the chip may then be used to capture biological substances.

[0047] In an exemplary embodiment, each characteristic site 110 can be attached to or retain one or more copies of a biomolecule sequence, and the positioning sequences of the multiple copies of the biomolecule sequence attached to or retained by the same characteristic site are the same, so that it can be determined that the substance captured by the probe at the same characteristic site has the same spatial position information corresponding to the position of the characteristic site. On the other hand, the biomolecule sequences attached to different characteristic sites have at least different positioning sequences, so that the spatial position of the captured biological substance can be distinguished and located. Further, the position of each characteristic site 110 on the front of the chip is mapped or corresponds to the spatial position indicated by the positioning sequence of the biomolecule sequence attached to the characteristic site, so that the subsequently captured biological substance (such as mRNA or cDNA) can be restored to its spatial position, for example, the omics information of the biological tissue or cell sample to be analyzed is corresponding to or associated with the image spatial site of the tissue sample according to the position information, thereby obtaining the spatial omics information of the tissue sample.

[0048] In a preferred embodiment, the biomolecule sequence attached to the characteristic site may include a DNA nanoball (DNB) and a probe connected to the DNB. The DNB is, for example, a product obtained by rolling circle amplification using a single-stranded circular DNA as a template. The DNBs fixed on the chip can be sequenced to obtain CID information. The CID corresponds one-to-one with the coordinate position of the DNB attached to each characteristic site. By establishing a mapping relationship between the CID and the coordinate position of the DNB, the mRNA subsequently captured by the probe connected to the DNB can be restored to its spatial position. Exemplarily, the nucleic acid molecule or each probe attached to the characteristic site (such as hybridizing with a carrier sequence) can contain or be linked to a unique molecular identifier (UMI) sequence (for example, for distinguishing different nucleic acid molecules or transcripts), and / or a polyT sequence containing an oligonucleotide, or other fragments or sequences for recognizing and binding to mRNA or cDNA, thereby enabling the capture of free mRNA. The captured product or information is then converted into a corresponding nucleotide sequence through a biochemical reaction and recovered. Finally, the cDNA or RNA in the recovered sample is sequenced through second-generation sequencing, and the captured information and spatial coordinates are matched one by one. The read content is superimposed on the tissue image, thereby generating a complete gene expression image of the tissue section.

[0049] The characteristic sites 110 formed on the chip can be defined by discrete grooves 103 (e.g., see Figures 4 and 5), micropores, microwells, protrusions, microbeads, or modified planar areas formed on the front side 101 of the chip, which are generally set to have dimensions suitable for attaching the above-mentioned biomolecule sequences, such as length, width, or possible depth or height. Exemplarily, the characteristic sites 110 can be arranged in an array on the front side 101, and the center spacing L between adjacent characteristic sites 110 can be in the range of 50nm to 900nm, preferably in the range of 100nm to 800nm, such as 900nm, 800nm, 750nm, 600nm, 500nm, or even 300nm, 100nm or 50nm. As an example, the diameter of the DNB can be 220nm or less, and the distance between the center points of two adjacent DNBs is 500nm or less, which can achieve spatial transcriptomics technology with higher resolution.

[0050] According to an exemplary embodiment of the present disclosure, the biochip 100 also has a mark for chip differentiation or identification. This identification mark is unique or specific to each biochip to distinguish it from other chips, so that different chips can be distinguished or identified based on this mark, such as for entering chip information, associating each chip with a spatial omics processing flow, determining the biochemical reaction process on each chip, establishing a correspondence or matching relationship between the obtained capture products, sequencing data and the detected biological tissue, etc.

[0051] In the embodiments shown in Figures 1 and 3, this identification mark is disposed or formed on the back surface 102 of the biochip 100. In other embodiments, if the front surface of the biochip is sufficiently large or allows for this, this identification mark can also be formed on the front surface of the chip to facilitate identification operations. For example, this mark can be formed on the chip by etching, coating, pasting, silk screen printing, printing, etc. Obviously, this identification mark does not participate in or interfere with subsequent biochemical reactions that will be carried out on the front surface of the chip.

[0052] As an example, as shown in Figures 1 and 3, the identification mark formed on the biochip 100 may include at least one of a first mark 120 recognizable by the human eye and a second mark 130 recognizable by an instrument. The formed first mark 120 and / or second mark 130 are unique to the biochip, that is, the first mark 120 and / or second mark 130 of one biochip are different from the first marks 120 and / or second marks 130 of other biochips. As an example, the first mark 120 and / or second mark 130 may include identification information for determining the identity of the biochip 100. This identification information is unique or specific to each biochip and can be used to distinguish between different biochips.

[0053] Exemplarily, the first marker can be formed to facilitate the human eye to distinguish and identify the chip during manual operation, and the second marker can be recognized by a spatial omics or spatiotemporal omics processing instrument, such as being read by a barcode scanner for system entry or association with a chip container, or used on the instrument to automatically scan and enter information, and be bound to the instrument's processing flow, etc., including through this marker in operations such as cleaning, waste liquid extraction, blocking liquid addition, antibody addition and incubation, permeabilization, reverse transcription, tissue removal, cDNA release, product recovery, staining, and imaging to identify the chip being processed or to be processed and / or its biochemical reaction process, results, etc., or quickly and conveniently find and identify the chip of interest from multiple chips.

[0054] In the embodiments of the present disclosure, the specific forms of the first mark 120 and the second mark 130 formed on the biochip 100 are not limited, and various suitable marks or combinations of marks that are recognizable to the human eye or an instrument may be used, including but not limited to optical marks, electrical marks, magnetic marks, etc. As an example, the first mark 120 may include a character number, such as a letter and / or numeric code, text, pattern, or a combination thereof that is recognizable to the human eye, and the second mark 130 may include a QR code, a barcode, or an electronic tag (such as an RF tag), or may also be letters, numbers, text, or patterns that are recognizable or readable by an instrument.

[0055] In the embodiments shown in Figures 1 and 3, a first marker 120 and a second marker 130 are arranged side by side on the back surface 102 of the biochip 100, so as to accurately identify the chip during both manual and automated instrument operation. In this case, the first marker and the second marker are preferably different. Such difference can be in type or size. For example, they can be of the same type but different size, or of the same size but different type, or both type and size. It will be understood that in some examples, the first marker for human visual recognition can be designed to be unrecognizable by instruments to avoid misidentification by the instruments.

[0056] In some examples, the overall dimensions of first mark 120 and second mark 130 do not exceed the surface area of ​​the chip backside, e.g., no more than 10 mm x 10 mm. For example, the total length of first mark 120 may not exceed 10 mm, and the width may be no less than 1 mm but no more than 10 mm; and / or the length and width of second mark 130 may each be no less than 1 μm. First mark 120 or second mark 130 may be engraved into backside 102, for example, to a depth of 3 μm to 10 μm, preferably 5 μm.

[0057] The biochip provided according to the embodiments of the present disclosure can be used in spatial omics or spatiotemporal omics analysis or sequencing instruments to perform spatial omics in situ information labeling, analysis, and capture. In an exemplary embodiment, as shown in FIG6 , a method for capturing, analyzing, or obtaining spatial omics information of a biological tissue sample is provided, which mainly includes the following steps:

[0058] S11: placing a biological tissue sample or slice onto the front side of the biochip described in any embodiment of the present disclosure, and loading the biochip into an analysis instrument;

[0059] S12: causing cellular material in the biological tissue sample or slice to undergo a biochemical reaction with the biomolecule sequence carried by the biochip to produce a capture object or reaction product containing the positioning sequence; for example, loading a frozen slice of fresh tissue onto the chip surface, followed by fixation, permeabilization, and finally reverse transcription and amplification; and

[0060] S13: Analyze the reaction products to restore the spatial location information of cells in the biological tissue sample based on the spatial locations indicated by the mapping sequences. For example, amplified cDNA can be collected and used as a template for library preparation, which is then sequenced along with the CID. Computational analysis of the sequencing data enables spatially resolved transcriptomics studies.

[0061] The spatial position information obtained can be used for analysis or sequencing of spatial omics (such as spatial transcriptome, spatial proteome, etc.), and can be used to mark the position information of cellular substances (such as RNA, DNA, protein, etc.) in biological tissues or the cell from which they come, so as to study the spatial specificity of these substances. For example, the captured products or information can be converted into corresponding nucleotide sequences through biochemical reactions and recovered, such as collecting amplified cDNA, and sequencing the cDNA or RNA in the recovered samples through, for example, second-generation sequencing technology, and the captured information is matched one-to-one with the spatial position information. The read content is superimposed on the captured image of the tissue, so that a complete gene expression image of the tissue section can be generated, such as constructing a spatial transcription map of the tissue in situ, which can characterize new cell clusters and cell-to-cell interactions in situ. After the spatiotemporal transcriptome information is matched with the clinical image, the relationship between pathological phenotypes and molecular information can be further studied, and the cellular heterogeneity and transcriptome changes of human tissues can be revealed with high resolution.

[0062] Before loading the biochip into the analytical instrument, the method may further include step S10: entering the unique identification information of the biochip into the analytical instrument based on the first marker 120 and / or the second marker 130, such as being read by a barcode scanner for system entry or association with a chip container, or being used on the instrument for automatic barcode scanning and entry of information; thereby, each chip can be associated or bound to a spatial omics processing flow, determining the biochemical reaction process on each chip (for example, including but not limited to cleaning, extraction of waste liquid, addition of blocking liquid, antibody addition and incubation, permeabilization, reverse transcription, tissue removal, cDNA release, product recovery, staining, imaging, etc.), establishing a correspondence or matching relationship between the obtained capture products, sequencing data and the detected biological tissue, etc., or quickly and conveniently finding and identifying a chip of interest from multiple chips.

[0063] It will be appreciated that the biochip provided according to the embodiments of the present disclosure can be applied not only to the capture of spatial omics, but also to omics markers and pathological markers, including but not limited to in situ fluorescence staining, conventional pathological staining, etc.

[0064] According to an exemplary embodiment of the present disclosure, a method for preparing a biochip is also provided, as shown in Figures 1 and 7, which mainly includes the following steps:

[0065] S20: providing a substrate 1 having a front surface and a back surface 11; the substrate includes, for example, a silicon wafer, a glass plate, or a polymer film;

[0066] S21: forming at least one of a first mark 120 and a second mark 130 on the back surface 11 of the substrate 1; for example, the first mark 120 or the second mark 130 may be formed on the back surface of the substrate by etching, coating, pasting, silk-screening, or printing;

[0067] S22: forming a plurality of characteristic sites 110 arranged in an array on the front surface of the substrate 1, such as grooves 103, micropores, microwells, protrusions, microbeads, or modified planar areas, for example, by physical, chemical, or biological methods; and

[0068] S23: For example, by physical or chemical methods or biochemical reactions, multiple biomolecule sequences are attached to multiple characteristic sites 110, each biomolecule sequence at least includes a positioning sequence, and the positioning sequence contains information indicating the spatial position of the biomolecule sequence on the biochip.

[0069] In some embodiments, the substrate to which the biomolecule sequences are attached can be cut into smaller chips for use in different applications. For example, referring to FIG7 , the method for preparing a biochip can further include step S24: after the plurality of biomolecule sequences are attached to the front surface of the substrate, the substrate is cut into a plurality of chip units, for example, using a manual tool or automated cutting equipment such as a laser cutter. Each of the cut chip units has at least one of the first and second markings that uniquely corresponds to the chip unit and has a predetermined size, so as to function as a single biochip.

[0070] While embodiments of the present disclosure have been shown and described, it will be appreciated by those skilled in the art that changes may be made to these embodiments without departing from the principles and spirit of the disclosure, the scope of which is defined in the appended claims and their equivalents.

Claims

1. A biochip comprising: a solid support having a front side and a back side; The front surface is formed with a plurality of characteristic sites (110) arranged in an array and a plurality of biomolecule sequences attached to the plurality of characteristic sites, each biomolecule sequence at least including a positioning sequence, the positioning sequence containing information indicating the spatial position of the biomolecule sequence on the biochip, and At least one of a first mark (120) identifiable to the human eye and a second mark (130) identifiable to an instrument is provided on the back surface.

2. The biochip according to claim 1, wherein Each biomolecule sequence also includes a probe for capturing the biological species.

3. The biochip according to claim 2, wherein The probe at least includes a capture sequence, which is connected to a positioning sequence and can perform a biochemical reaction with the biological substance to be captured.

4. The biochip according to claim 1, wherein Each characteristic site (110) is attached with one or more copies of a biomolecule sequence, and the positioning sequences of the multiple copies of the biomolecule sequence attached to the same characteristic site are the same.

5. The biochip according to claim 4, wherein The biomolecule sequence includes a nucleic acid molecule.

6. The biochip according to claim 5, wherein The nucleic acid molecules include DNA nanoballs.

7. The biochip according to claim 5, wherein Each biomolecule sequence also includes an anchor sequence that allows the complementary nucleotide sequence to anneal and initiate an extension reaction.

8. The biochip according to claim 5, wherein The nucleic acid molecule comprises a unique molecular identifier (UMI) sequence, and the positioning sequence comprises a coordinate identification (CID) sequence.

9. The biochip according to claim 1, wherein At least the positioning sequences of the biomolecule sequences attached to different characteristic sites are different.

10. The biochip according to claim 9, wherein The position of each characteristic site (110) on the front surface is mapped one-to-one to the spatial position indicated by the positioning sequence of the biomolecule sequence attached to the characteristic site.

11. The biochip according to any one of claims 1 to 10, wherein: The characteristic sites are defined by grooves (103), micropores, protrusions or modified planar areas formed on the front surface.

12. The biochip according to any one of claims 1 to 10, wherein: The center-to-center distance (L) between adjacent characteristic sites (110) is in the range of 100 nm to 800 nm.

13. The biochip according to any one of claims 1 to 10, wherein: The first mark (120) and / or the second mark (130) contain unique identification information for determining the identity of the biochip.

14. The biochip according to any one of claims 1 to 10, wherein: The first mark (120) includes a character number, and the second mark (130) includes a QR code, a bar code or an electronic tag.

15. The biochip according to any one of claims 1 to 10, wherein: The first mark (120) and the second mark (130) are both arranged side by side on the back surface (102).

16. The biochip according to any one of claims 1 to 10, wherein: The biochip has a rectangular shape with a size ranging from 0.5 cm×0.5 cm to 10 cm×10 cm.

17. The biochip according to claim 16, wherein The biochip has a rectangular shape with a size ranging from 1 cm×1 cm to 6 cm×6 cm.

18. The biochip according to any one of claims 1 to 10, wherein: The biochip is made of silicon, glass or polymer material.

19. A method for analyzing spatial omics information of a biological tissue sample, comprising: placing a biological tissue sample onto the front side of the biochip according to any one of claims 1 to 18, and loading the biochip into an analytical instrument; allowing a biological tissue sample to undergo a biochemical reaction with the plurality of biomolecule sequences of the biochip to generate a reaction product containing the positioning sequence; as well as The reaction product is analyzed to restore the spatial position information of the cells in the biological tissue sample based on the spatial position indicated by the positioning sequence.

20. The method according to claim 19, further comprising: Before the biochip is loaded into an analytical instrument, the unique identification information of the biochip is entered into the analytical instrument based on the first mark (120) and / or the second mark (130).

21. A method for preparing the biochip according to any one of claims 1 to 18, comprising: providing a substrate having a front side and a back side; forming at least one of the first mark (120) and the second mark (130) on the back surface of the substrate; forming a plurality of characteristic sites (110) arranged in an array on the front surface of the substrate; and A plurality of biomolecule sequences are attached to the plurality of characteristic sites, each biomolecule sequence at least comprising a positioning sequence, wherein the positioning sequence contains information indicating the spatial position of the biomolecule sequence on the biochip.

22. The method according to claim 21, wherein The first mark or the second mark is formed on the back surface by at least one of etching, coating, pasting and printing.

23. The method according to claim 21 or 22, wherein The substrate comprises a silicon wafer, a glass plate or a polymer film, and the method further comprises: After a plurality of biomolecule sequences are attached to the front surface, the substrate is cut into a plurality of chip units, each of the cut chip units having at least one of a first mark and a second mark that is uniquely corresponding to the chip unit and having a predetermined size to be used as a single biochip.